Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention
- PMID: 31926642
- DOI: 10.1016/j.ijcard.2019.12.042
Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention
Abstract
Background: Coronary microvascular dysfunction before percutaneous coronary intervention (PCI) predicts PCI-related myocardial injury in patients with stable coronary artery disease (CAD). Whether the dynamic changes of the microcirculation during PCI might be associated with the occurrence of procedure-related myocardial injury and infarction is still unclear. We aimed to investigate the impact of pre- and post-PCI microvascular function, evaluated with the index of microvascular resistance (IMR) on the occurrence of PCI-related myocardial injury and infarction.
Methods: In consecutive patients with stable CAD referred for elective PCI, coronary physiological indexes, including IMR, were measured before and after revascularization. High sensitivity Troponin T (hs-TnT) was assessed up to 24 h after PCI, and PCI-related myocardial injury and type 4a myocardial infarction (MI) were defined according to the fourth universal definition of myocardial infarction.
Results: In the 50 patients enrolled, a significant correlation was found between maximum post-PCI hs-Tn and IMR, both at baseline (rho = 0.309, p=0.029) and post-PCI (rho = 0.378, p=0.007). Patients who developed type 4a MI, compared with patients who did not, presented significantly higher IMR levels, both at baseline (28.3 ± 12.2 vs. 19.6 ± 8.8, p=0.020) and post-PCI (45.4 ± 21.3 vs. 21.6 ± 11.2, p<0.0001). Patients with post-PCI IMR > 38 showed significantly higher maximum post-PCI hs-Tn levels (105.4 [49.4-126.9] vs. 22.4 [11.7-38.6] ng/ml, p<0.0001), and developed type 4a MI more frequently (66.8% vs. 4.9%, p<0.0001).
Conclusions: Dynamic changes of microvascular resistance post-PCI are strongly correlated with PCI-related myocardial injury and post-PCI IMR is a strong predictor of type 4a MI in patients with stable CAD undergoing elective PCI.
Keywords: Coronary artery disease; Coronary microvascular function; Myocardial infarction; Percutaneous coronary intervention.
Copyright © 2019 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors report no relationships that could be construed as a conflict of interest. All authors have approved the final article.
Comment in
-
Understanding pathophysiological mechanisms of PCI-related AMI.Int J Cardiol. 2020 May 1;306:47-48. doi: 10.1016/j.ijcard.2020.02.071. Int J Cardiol. 2020. PMID: 32276712 No abstract available.
-
Nicorandil, a promising drug for the prevention of percutaneous coronary artery intervention-related myocardial injury and infarction in patients with stable coronary artery disease.Int J Cardiol. 2020 Jun 1;308:10. doi: 10.1016/j.ijcard.2020.02.046. Int J Cardiol. 2020. PMID: 32334803 No abstract available.
-
Microvascular impairment associated with percutaneous coronary revascularization: The quest for protective microcirculatory strategies.Int J Cardiol. 2020 Jun 1;308:9. doi: 10.1016/j.ijcard.2020.03.029. Int J Cardiol. 2020. PMID: 32334805 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
